Greg is a partner at the firm and a leader in the firm’s Biotechnology patent group. He prepares and prosecutes U.S., foreign, and international patent applications. Greg also advises clients about patentability, inventorship, freedom-to-operate, and strategic product development.
Greg’s expertise covers many areas of biotechnology, including virology, immunology, oncology, neurobiology, and biochemistry. He has particular expertise in the patenting of engineered vaccines and antibodies, including live-attenuated, subunit, and mRNA vaccines, monoclonal antibodies, bispecific antibodies, antibody conjugates, and CAR T cells.
Greg has prepared and prosecuted patents for multiple technologies shown in Science Magazine’s annual “breakthrough of the year” list and manages several global patent portfolios that cover FDA-licensed large molecule therapeutics.
Greg joined Klarquist in 2007 as a summer associate and student law clerk. He became partner in 2018.
J.D., cum laude, Lewis & Clark Law School, 2010
Ph.D., Neuroscience, Oregon Health & Science University, 2006
B.S., Neuroscience, Bates College, 1997
U.S. Patent and Trademark Office, 2007 (Reg. No. 60,185)
Life Sciences & Biotechnology Medical Devices & Diagnostics Chemical
Vollum Institute, Oregon Health & Science University | Graduate Student, 1999–2006; Laboratory Technician, 1997–1999 | Portland, OR | Responsible for design and completion of original biomedical research concerning structure and function of adaptor proteins and enzymes in the endosomal system.
The Jackson Laboratory | Student and intern, 1996 | Bar Harbor, ME | Responsible for design and implementation of original genetics research concerning animal models of human atherosclerosis.
HBS Products | Machinist, 1990–1995 (part-time) | Beverly, MA | Operated robotic and mechanical lathes in a machine shop.
Member, American Intellectual Property Law Association
Member, Licensing Executives Society
Member, Oregon Patent Law Association
Honors & Awards
The Best Lawyer’s Ones to Watch, Portland, OR, IP Law | 2021-2024
IAM Patent 1000: The World’s Leading Patent Professionals | 2020-2023
Presentations & Publications
Scott G.K., Understanding Patent Claims, National Institutes of Health, 2021.
Scott G.K., Determining inventorship for chemistry patent applications, National Institutes of Health, 2019.
Scott G.K., Patenting Antibodies in the United States, Europe, and China, National Institutes of Health, 2018.
Scott G.K., Determining inventorship for antibody patent applications, National Institutes of Health, 2017.
Scott G.K., Patenting in the life sciences, Oregon State University, 2017.
Scott G.K., Patenting & licensing of software inventions, National Institutes of Health, 2016
Scott G.K., Biomarker patents after Prometheus and Myriad, SelectBio Exosomes & Single Cell Conference, 2014.
Scott G.K., H. Fei, L. Thomas, G.R. Megideshi, G. Thomas, A PACS-1, GGA3 and CK2 complex regulates CI- MPR trafficking, EMBO J., 25(19):4423-35, 2006.
Feliciangeli S.F., L. Thomas, G.K. Scott, E. Subbian, C.H. Hung, S.S. Molloy, F. Jean, U. Shinde and G. Thomas, Identification of a pH sensor in the furin propeptide that regulates enzyme activation, J. Biol. Chem., 281(23):16108- 16, 2006.
Grose, C., M. Maresova, G.R. Medigeshi, G.K. Scott, and G. Thomas, (2006) Endocytosis of varicella-Roster virus Glycoprotein: virion envelopment and egress. In Alpha Herpesviruses: Molecular and cellular biology, R.M. Sandri-Goldin (Ed.), pp 178-19, Hethersett: Caister Academic Press.
Scott G.K., F. Gu, C.M. Crump, L. Thomas, L. Wan, Y. Xiang, G. Thomas. The phosphorylation state of an autoregulatory domain controls PACS-1-directed protein traffic, EMBO J., 22(23):6234-44, 2003.
Colledge M., R.A. Dean, G.K. Scott, L.K. Langeberg, R.L. Huganir, J.D. Scott, Targeting of PKA to glutamate receptors through a MAGUK-AKAP complex, Neuron, 27(1):107-19, 2000.
Trotter K.W., I.D. Fraser, G.K. Scott, M.J. Stutts, J.D. Scott, S.L. Milgram, Alternative splicing regulates the subcellular localization of A-kinase anchoring protein 18 isoforms, J. Cell Biol., 147(7):1481-92, 1999.